Copyright Reports & Markets. All rights reserved.

Global and United States Continuous Subcutaneous Insulin Infusion Therapy Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Continuous Subcutaneous Insulin Infusion Therapy Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Continuous Subcutaneous Insulin Infusion Therapy Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size for the Year 2017-2028
      • 1.2.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size for the Year 2017-2028
    • 1.3 Continuous Subcutaneous Insulin Infusion Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Continuous Subcutaneous Insulin Infusion Therapy in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Continuous Subcutaneous Insulin Infusion Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Continuous Subcutaneous Insulin Infusion Therapy Market Dynamics
      • 1.4.1 Continuous Subcutaneous Insulin Infusion Therapy Industry Trends
      • 1.4.2 Continuous Subcutaneous Insulin Infusion Therapy Market Drivers
      • 1.4.3 Continuous Subcutaneous Insulin Infusion Therapy Market Challenges
      • 1.4.4 Continuous Subcutaneous Insulin Infusion Therapy Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Continuous Subcutaneous Insulin Infusion Therapy by Type

    • 2.1 Continuous Subcutaneous Insulin Infusion Therapy Market Segment by Type
      • 2.1.1 Normal
      • 2.1.2 Patch Pump
    • 2.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2017, 2022 & 2028)
    • 2.3 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2017-2028)
    • 2.4 United States Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2017, 2022 & 2028)
    • 2.5 United States Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2017-2028)

    3 Continuous Subcutaneous Insulin Infusion Therapy by Application

    • 3.1 Continuous Subcutaneous Insulin Infusion Therapy Market Segment by Application
      • 3.1.1 Hospital
      • 3.1.2 Retail Pharmacy
      • 3.1.3 Other
    • 3.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2017-2028)
    • 3.4 United States Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2017-2028)

    4 Global Continuous Subcutaneous Insulin Infusion Therapy Competitor Landscape by Company

    • 4.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Company
      • 4.1.1 Top Global Continuous Subcutaneous Insulin Infusion Therapy Companies Ranked by Revenue (2021)
      • 4.1.2 Global Continuous Subcutaneous Insulin Infusion Therapy Revenue by Player (2017-2022)
    • 4.2 Global Continuous Subcutaneous Insulin Infusion Therapy Concentration Ratio (CR)
      • 4.2.1 Continuous Subcutaneous Insulin Infusion Therapy Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Continuous Subcutaneous Insulin Infusion Therapy in 2021
      • 4.2.3 Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Continuous Subcutaneous Insulin Infusion Therapy Headquarters, Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Continuous Subcutaneous Insulin Infusion Therapy Headquarters and Area Served
      • 4.3.2 Global Continuous Subcutaneous Insulin Infusion Therapy Companies Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Continuous Subcutaneous Insulin Infusion Therapy Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Continuous Subcutaneous Insulin Infusion Therapy Market Size by Company
      • 4.5.1 Top Continuous Subcutaneous Insulin Infusion Therapy Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Continuous Subcutaneous Insulin Infusion Therapy Revenue by Players (2020, 2021 & 2022)

    5 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region

    • 5.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region (2017-2028)
      • 5.2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region: 2017-2022
      • 5.2.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth 2017-2028
      • 6.1.2 North America Continuous Subcutaneous Insulin Infusion Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Continuous Subcutaneous Insulin Infusion Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Continuous Subcutaneous Insulin Infusion Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Medtronic
      • 7.1.1 Medtronic Company Details
      • 7.1.2 Medtronic Business Overview
      • 7.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Therapy Introduction
      • 7.1.4 Medtronic Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022)
      • 7.1.5 Medtronic Recent Development
    • 7.2 Roche
      • 7.2.1 Roche Company Details
      • 7.2.2 Roche Business Overview
      • 7.2.3 Roche Continuous Subcutaneous Insulin Infusion Therapy Introduction
      • 7.2.4 Roche Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022)
      • 7.2.5 Roche Recent Development
    • 7.3 SOOIL
      • 7.3.1 SOOIL Company Details
      • 7.3.2 SOOIL Business Overview
      • 7.3.3 SOOIL Continuous Subcutaneous Insulin Infusion Therapy Introduction
      • 7.3.4 SOOIL Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022)
      • 7.3.5 SOOIL Recent Development
    • 7.4 Tandem Diabetes care
      • 7.4.1 Tandem Diabetes care Company Details
      • 7.4.2 Tandem Diabetes care Business Overview
      • 7.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Introduction
      • 7.4.4 Tandem Diabetes care Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022)
      • 7.4.5 Tandem Diabetes care Recent Development
    • 7.5 Insulet Corp
      • 7.5.1 Insulet Corp Company Details
      • 7.5.2 Insulet Corp Business Overview
      • 7.5.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Introduction
      • 7.5.4 Insulet Corp Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022)
      • 7.5.5 Insulet Corp Recent Development
    • 7.6 Valeritas
      • 7.6.1 Valeritas Company Details
      • 7.6.2 Valeritas Business Overview
      • 7.6.3 Valeritas Continuous Subcutaneous Insulin Infusion Therapy Introduction
      • 7.6.4 Valeritas Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022)
      • 7.6.5 Valeritas Recent Development
    • 7.7 Microport
      • 7.7.1 Microport Company Details
      • 7.7.2 Microport Business Overview
      • 7.7.3 Microport Continuous Subcutaneous Insulin Infusion Therapy Introduction
      • 7.7.4 Microport Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022)
      • 7.7.5 Microport Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:

      An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.
      Market Analysis and Insights: Global and United States Continuous Subcutaneous Insulin Infusion Therapy Market
      This report focuses on global and United States Continuous Subcutaneous Insulin Infusion Therapy market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Continuous Subcutaneous Insulin Infusion Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Normal accounting for % of the Continuous Subcutaneous Insulin Infusion Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Continuous Subcutaneous Insulin Infusion Therapy market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
      Global Continuous Subcutaneous Insulin Infusion Therapy Scope and Market Size
      Continuous Subcutaneous Insulin Infusion Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Continuous Subcutaneous Insulin Infusion Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Continuous Subcutaneous Insulin Infusion Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Continuous Subcutaneous Insulin Infusion Therapy market is segmented into
      Normal
      Patch Pump
      Segment by Application, the Continuous Subcutaneous Insulin Infusion Therapy market is segmented into
      Hospital
      Retail Pharmacy
      Other
      Regional and Country-level Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Continuous Subcutaneous Insulin Infusion Therapy Market Share Analysis
      Continuous Subcutaneous Insulin Infusion Therapy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Continuous Subcutaneous Insulin Infusion Therapy business, the date to enter into the Continuous Subcutaneous Insulin Infusion Therapy market, Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
      The major vendors covered:
      Medtronic
      Roche
      SOOIL
      Tandem Diabetes care
      Insulet Corp
      Valeritas
      Microport
      Buy now